COMPLERA

Identification of Complera

Examples of the descriptions of OTHER drugs:

Google image searchProduct monograph

Active ingredients

emtricitabine, 200 MG

rilpivirine (rilpivirine hydrochloride), 25 MG

tenofovir disoproxil fumarate, 300 MG

DIN: 02374129

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: GILEAD SCIENCES CANADA INC

Date: 04-OCT-2014

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
• J05AR08 — EMTRICITABINE, TENOFOVIR DISOPROXIL AND RILPIVIRINE (ATC/DDD)

Reference brand drug: Complera

External Links for Complera

Search on Google

• Complera side effects
• Complera dosage
• emtricitabine side effects
• emtricitabine dosage
• rilpivirine side effects
• rilpivirine dosage
• tenofovir disoproxil fumarate side effects
• tenofovir disoproxil fumarate dosage